Study Evaluating IMA-638 in Healthy Japanese

Wyeth

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: IMA-638

Study type: Interventional

Funder types: Industry

Identifiers

NCT00340327

3174K1-101

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and drug levels for single, ascending doses of IMA-638 in healthy Japanese subjects.

Sex: All

Ages: 20 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• First generation healthy Japanese men and women of non-childbearing potential.

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind